Global Microbiome Therapeutics Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
According to APO Research, The global Microbiome Therapeutics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Microbiome Therapeutics include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma and Second Genome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Therapeutics.
The Microbiome Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiome Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbiome Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiome Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Microbiome Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
According to APO Research, The global Microbiome Therapeutics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Microbiome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Microbiome Therapeutics include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma and Second Genome, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Therapeutics.
The Microbiome Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Seres Therapeutics
- Assembly Biosciences
- Synthetic Biologics
- Interxon
- PureTech
- Synlogic
- Enterome BioScience
- 4D Pharma
- Second Genome
- AOBiome
- C3 Jian
- Rebiotix
- MicroBiome Therapeutics LLC
- Metabiomics
- Ritter Pharmaceuticals
- Symberix
- OpenBiome
- Azitra
- Symbiotix Biotherapies
- Osel
- Metabogen
- Upper GIT
- Lower GIT
- C. difficile Infection (CDI)
- Inflammatory Bowel Disease (IBD)
- Orphan Drug
- Immuno-oncology
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiome Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbiome Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiome Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Microbiome Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Microbiome Therapeutics Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Microbiome Therapeutics Market Size by Region (2019-2030)
1.4.1 Global Microbiome Therapeutics Market Size by Region (2019-2024)
1.4.2 Global Microbiome Therapeutics Market Size by Region (2025-2030)
1.5 Key Regions Microbiome Therapeutics Market Size (2019-2030)
1.5.1 North America Microbiome Therapeutics Market Size Growth Rate (2019-2030)
1.5.2 Europe Microbiome Therapeutics Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Microbiome Therapeutics Market Size Growth Rate (2019-2030)
1.5.4 Latin America Microbiome Therapeutics Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Microbiome Therapeutics Market Size Growth Rate (2019-2030)
2 MICROBIOME THERAPEUTICS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Upper GIT
2.1.2 Lower GIT
2.2 Global Microbiome Therapeutics Market Size by Type
2.2.1 Global Microbiome Therapeutics Market Size Overview by Type (2019-2030)
2.2.2 Global Microbiome Therapeutics Historic Market Size Review by Type (2019-2024)
2.2.3 Global Microbiome Therapeutics Market Size Forecasted by Type (2025-2030)
2.3 Global Microbiome Therapeutics Market Size by Regions
2.3.1 North America Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
3 MICROBIOME THERAPEUTICS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 C. difficile Infection (CDI)
3.1.2 Inflammatory Bowel Disease (IBD)
3.1.3 Orphan Drug
3.1.4 Immuno-oncology
3.1.5 Others
3.2 Global Microbiome Therapeutics Market Size by Application
3.2.1 Global Microbiome Therapeutics Market Size Overview by Application (2019-2030)
3.2.2 Global Microbiome Therapeutics Historic Market Size Review by Application (2019-2024)
3.2.3 Global Microbiome Therapeutics Market Size Forecasted by Application (2025-2030)
3.3 Global Microbiome Therapeutics Market Size by Regions
3.3.1 North America Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Microbiome Therapeutics Industry Trends
4.2 Microbiome Therapeutics Industry Drivers
4.3 Microbiome Therapeutics Industry Opportunities and Challenges
4.4 Microbiome Therapeutics Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Microbiome Therapeutics Revenue (2019-2024)
5.2 Global Microbiome Therapeutics Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Microbiome Therapeutics Key Company Headquarters & Area Served
5.4 Global Microbiome Therapeutics Company, Product Type & Application
5.5 Global Microbiome Therapeutics Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Microbiome Therapeutics Market CR5 and HHI
5.6.2 Global Top 5 and 10 Microbiome Therapeutics Players Market Share by Revenue in 2023
5.6.3 2023 Microbiome Therapeutics Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Comapny Information
6.1.2 Seres Therapeutics Business Overview
6.1.3 Seres Therapeutics Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Seres Therapeutics Microbiome Therapeutics Product Portfolio
6.1.5 Seres Therapeutics Recent Developments
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Comapny Information
6.2.2 Assembly Biosciences Business Overview
6.2.3 Assembly Biosciences Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Assembly Biosciences Microbiome Therapeutics Product Portfolio
6.2.5 Assembly Biosciences Recent Developments
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Comapny Information
6.3.2 Synthetic Biologics Business Overview
6.3.3 Synthetic Biologics Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Synthetic Biologics Microbiome Therapeutics Product Portfolio
6.3.5 Synthetic Biologics Recent Developments
6.4 Interxon
6.4.1 Interxon Comapny Information
6.4.2 Interxon Business Overview
6.4.3 Interxon Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Interxon Microbiome Therapeutics Product Portfolio
6.4.5 Interxon Recent Developments
6.5 PureTech
6.5.1 PureTech Comapny Information
6.5.2 PureTech Business Overview
6.5.3 PureTech Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 PureTech Microbiome Therapeutics Product Portfolio
6.5.5 PureTech Recent Developments
6.6 Synlogic
6.6.1 Synlogic Comapny Information
6.6.2 Synlogic Business Overview
6.6.3 Synlogic Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Synlogic Microbiome Therapeutics Product Portfolio
6.6.5 Synlogic Recent Developments
6.7 Enterome BioScience
6.7.1 Enterome BioScience Comapny Information
6.7.2 Enterome BioScience Business Overview
6.7.3 Enterome BioScience Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Enterome BioScience Microbiome Therapeutics Product Portfolio
6.7.5 Enterome BioScience Recent Developments
6.8 4D Pharma
6.8.1 4D Pharma Comapny Information
6.8.2 4D Pharma Business Overview
6.8.3 4D Pharma Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 4D Pharma Microbiome Therapeutics Product Portfolio
6.8.5 4D Pharma Recent Developments
6.9 Second Genome
6.9.1 Second Genome Comapny Information
6.9.2 Second Genome Business Overview
6.9.3 Second Genome Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Second Genome Microbiome Therapeutics Product Portfolio
6.9.5 Second Genome Recent Developments
6.10 AOBiome
6.10.1 AOBiome Comapny Information
6.10.2 AOBiome Business Overview
6.10.3 AOBiome Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 AOBiome Microbiome Therapeutics Product Portfolio
6.10.5 AOBiome Recent Developments
6.11 C3 Jian
6.11.1 C3 Jian Comapny Information
6.11.2 C3 Jian Business Overview
6.11.3 C3 Jian Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 C3 Jian Microbiome Therapeutics Product Portfolio
6.11.5 C3 Jian Recent Developments
6.12 Rebiotix
6.12.1 Rebiotix Comapny Information
6.12.2 Rebiotix Business Overview
6.12.3 Rebiotix Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Rebiotix Microbiome Therapeutics Product Portfolio
6.12.5 Rebiotix Recent Developments
6.13 MicroBiome Therapeutics LLC
6.13.1 MicroBiome Therapeutics LLC Comapny Information
6.13.2 MicroBiome Therapeutics LLC Business Overview
6.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Portfolio
6.13.5 MicroBiome Therapeutics LLC Recent Developments
6.14 Metabiomics
6.14.1 Metabiomics Comapny Information
6.14.2 Metabiomics Business Overview
6.14.3 Metabiomics Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Metabiomics Microbiome Therapeutics Product Portfolio
6.14.5 Metabiomics Recent Developments
6.15 Ritter Pharmaceuticals
6.15.1 Ritter Pharmaceuticals Comapny Information
6.15.2 Ritter Pharmaceuticals Business Overview
6.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
6.15.5 Ritter Pharmaceuticals Recent Developments
6.16 Symberix
6.16.1 Symberix Comapny Information
6.16.2 Symberix Business Overview
6.16.3 Symberix Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Symberix Microbiome Therapeutics Product Portfolio
6.16.5 Symberix Recent Developments
6.17 OpenBiome
6.17.1 OpenBiome Comapny Information
6.17.2 OpenBiome Business Overview
6.17.3 OpenBiome Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 OpenBiome Microbiome Therapeutics Product Portfolio
6.17.5 OpenBiome Recent Developments
6.18 Azitra
6.18.1 Azitra Comapny Information
6.18.2 Azitra Business Overview
6.18.3 Azitra Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Azitra Microbiome Therapeutics Product Portfolio
6.18.5 Azitra Recent Developments
6.19 Symbiotix Biotherapies
6.19.1 Symbiotix Biotherapies Comapny Information
6.19.2 Symbiotix Biotherapies Business Overview
6.19.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
6.19.5 Symbiotix Biotherapies Recent Developments
6.20 Osel
6.20.1 Osel Comapny Information
6.20.2 Osel Business Overview
6.20.3 Osel Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 Osel Microbiome Therapeutics Product Portfolio
6.20.5 Osel Recent Developments
6.21 Metabogen
6.21.1 Metabogen Comapny Information
6.21.2 Metabogen Business Overview
6.21.3 Metabogen Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 Metabogen Microbiome Therapeutics Product Portfolio
6.21.5 Metabogen Recent Developments
7 NORTH AMERICA
7.1 North America Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Microbiome Therapeutics Market Size by Country (2019-2024)
7.3 North America Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Microbiome Therapeutics Market Size by Country (2019-2024)
8.3 Europe Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Microbiome Therapeutics Market Size by Country (2019-2024)
9.3 Asia-Pacific Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Microbiome Therapeutics Market Size by Country (2019-2024)
10.3 Latin America Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Microbiome Therapeutics Market Size by Country (2019-2024)
11.3 Middle East & Africa Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Microbiome Therapeutics Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Microbiome Therapeutics Market Size by Region (2019-2030)
1.4.1 Global Microbiome Therapeutics Market Size by Region (2019-2024)
1.4.2 Global Microbiome Therapeutics Market Size by Region (2025-2030)
1.5 Key Regions Microbiome Therapeutics Market Size (2019-2030)
1.5.1 North America Microbiome Therapeutics Market Size Growth Rate (2019-2030)
1.5.2 Europe Microbiome Therapeutics Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Microbiome Therapeutics Market Size Growth Rate (2019-2030)
1.5.4 Latin America Microbiome Therapeutics Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Microbiome Therapeutics Market Size Growth Rate (2019-2030)
2 MICROBIOME THERAPEUTICS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Upper GIT
2.1.2 Lower GIT
2.2 Global Microbiome Therapeutics Market Size by Type
2.2.1 Global Microbiome Therapeutics Market Size Overview by Type (2019-2030)
2.2.2 Global Microbiome Therapeutics Historic Market Size Review by Type (2019-2024)
2.2.3 Global Microbiome Therapeutics Market Size Forecasted by Type (2025-2030)
2.3 Global Microbiome Therapeutics Market Size by Regions
2.3.1 North America Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Type (2019-2024)
3 MICROBIOME THERAPEUTICS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 C. difficile Infection (CDI)
3.1.2 Inflammatory Bowel Disease (IBD)
3.1.3 Orphan Drug
3.1.4 Immuno-oncology
3.1.5 Others
3.2 Global Microbiome Therapeutics Market Size by Application
3.2.1 Global Microbiome Therapeutics Market Size Overview by Application (2019-2030)
3.2.2 Global Microbiome Therapeutics Historic Market Size Review by Application (2019-2024)
3.2.3 Global Microbiome Therapeutics Market Size Forecasted by Application (2025-2030)
3.3 Global Microbiome Therapeutics Market Size by Regions
3.3.1 North America Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Microbiome Therapeutics Industry Trends
4.2 Microbiome Therapeutics Industry Drivers
4.3 Microbiome Therapeutics Industry Opportunities and Challenges
4.4 Microbiome Therapeutics Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Microbiome Therapeutics Revenue (2019-2024)
5.2 Global Microbiome Therapeutics Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Microbiome Therapeutics Key Company Headquarters & Area Served
5.4 Global Microbiome Therapeutics Company, Product Type & Application
5.5 Global Microbiome Therapeutics Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Microbiome Therapeutics Market CR5 and HHI
5.6.2 Global Top 5 and 10 Microbiome Therapeutics Players Market Share by Revenue in 2023
5.6.3 2023 Microbiome Therapeutics Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Comapny Information
6.1.2 Seres Therapeutics Business Overview
6.1.3 Seres Therapeutics Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Seres Therapeutics Microbiome Therapeutics Product Portfolio
6.1.5 Seres Therapeutics Recent Developments
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Comapny Information
6.2.2 Assembly Biosciences Business Overview
6.2.3 Assembly Biosciences Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Assembly Biosciences Microbiome Therapeutics Product Portfolio
6.2.5 Assembly Biosciences Recent Developments
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Comapny Information
6.3.2 Synthetic Biologics Business Overview
6.3.3 Synthetic Biologics Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Synthetic Biologics Microbiome Therapeutics Product Portfolio
6.3.5 Synthetic Biologics Recent Developments
6.4 Interxon
6.4.1 Interxon Comapny Information
6.4.2 Interxon Business Overview
6.4.3 Interxon Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Interxon Microbiome Therapeutics Product Portfolio
6.4.5 Interxon Recent Developments
6.5 PureTech
6.5.1 PureTech Comapny Information
6.5.2 PureTech Business Overview
6.5.3 PureTech Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 PureTech Microbiome Therapeutics Product Portfolio
6.5.5 PureTech Recent Developments
6.6 Synlogic
6.6.1 Synlogic Comapny Information
6.6.2 Synlogic Business Overview
6.6.3 Synlogic Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Synlogic Microbiome Therapeutics Product Portfolio
6.6.5 Synlogic Recent Developments
6.7 Enterome BioScience
6.7.1 Enterome BioScience Comapny Information
6.7.2 Enterome BioScience Business Overview
6.7.3 Enterome BioScience Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Enterome BioScience Microbiome Therapeutics Product Portfolio
6.7.5 Enterome BioScience Recent Developments
6.8 4D Pharma
6.8.1 4D Pharma Comapny Information
6.8.2 4D Pharma Business Overview
6.8.3 4D Pharma Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 4D Pharma Microbiome Therapeutics Product Portfolio
6.8.5 4D Pharma Recent Developments
6.9 Second Genome
6.9.1 Second Genome Comapny Information
6.9.2 Second Genome Business Overview
6.9.3 Second Genome Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Second Genome Microbiome Therapeutics Product Portfolio
6.9.5 Second Genome Recent Developments
6.10 AOBiome
6.10.1 AOBiome Comapny Information
6.10.2 AOBiome Business Overview
6.10.3 AOBiome Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 AOBiome Microbiome Therapeutics Product Portfolio
6.10.5 AOBiome Recent Developments
6.11 C3 Jian
6.11.1 C3 Jian Comapny Information
6.11.2 C3 Jian Business Overview
6.11.3 C3 Jian Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 C3 Jian Microbiome Therapeutics Product Portfolio
6.11.5 C3 Jian Recent Developments
6.12 Rebiotix
6.12.1 Rebiotix Comapny Information
6.12.2 Rebiotix Business Overview
6.12.3 Rebiotix Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Rebiotix Microbiome Therapeutics Product Portfolio
6.12.5 Rebiotix Recent Developments
6.13 MicroBiome Therapeutics LLC
6.13.1 MicroBiome Therapeutics LLC Comapny Information
6.13.2 MicroBiome Therapeutics LLC Business Overview
6.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Portfolio
6.13.5 MicroBiome Therapeutics LLC Recent Developments
6.14 Metabiomics
6.14.1 Metabiomics Comapny Information
6.14.2 Metabiomics Business Overview
6.14.3 Metabiomics Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Metabiomics Microbiome Therapeutics Product Portfolio
6.14.5 Metabiomics Recent Developments
6.15 Ritter Pharmaceuticals
6.15.1 Ritter Pharmaceuticals Comapny Information
6.15.2 Ritter Pharmaceuticals Business Overview
6.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
6.15.5 Ritter Pharmaceuticals Recent Developments
6.16 Symberix
6.16.1 Symberix Comapny Information
6.16.2 Symberix Business Overview
6.16.3 Symberix Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Symberix Microbiome Therapeutics Product Portfolio
6.16.5 Symberix Recent Developments
6.17 OpenBiome
6.17.1 OpenBiome Comapny Information
6.17.2 OpenBiome Business Overview
6.17.3 OpenBiome Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 OpenBiome Microbiome Therapeutics Product Portfolio
6.17.5 OpenBiome Recent Developments
6.18 Azitra
6.18.1 Azitra Comapny Information
6.18.2 Azitra Business Overview
6.18.3 Azitra Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Azitra Microbiome Therapeutics Product Portfolio
6.18.5 Azitra Recent Developments
6.19 Symbiotix Biotherapies
6.19.1 Symbiotix Biotherapies Comapny Information
6.19.2 Symbiotix Biotherapies Business Overview
6.19.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
6.19.5 Symbiotix Biotherapies Recent Developments
6.20 Osel
6.20.1 Osel Comapny Information
6.20.2 Osel Business Overview
6.20.3 Osel Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 Osel Microbiome Therapeutics Product Portfolio
6.20.5 Osel Recent Developments
6.21 Metabogen
6.21.1 Metabogen Comapny Information
6.21.2 Metabogen Business Overview
6.21.3 Metabogen Microbiome Therapeutics Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 Metabogen Microbiome Therapeutics Product Portfolio
6.21.5 Metabogen Recent Developments
7 NORTH AMERICA
7.1 North America Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Microbiome Therapeutics Market Size by Country (2019-2024)
7.3 North America Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Microbiome Therapeutics Market Size by Country (2019-2024)
8.3 Europe Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Microbiome Therapeutics Market Size by Country (2019-2024)
9.3 Asia-Pacific Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Microbiome Therapeutics Market Size by Country (2019-2024)
10.3 Latin America Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Microbiome Therapeutics Market Size by Country (2019-2024)
11.3 Middle East & Africa Microbiome Therapeutics Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global Microbiome Therapeutics Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Microbiome Therapeutics Market Share by Region (2019-2024)
Table 4. Global Microbiome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Microbiome Therapeutics Market Share by Region (2025-2030)
Table 6. Global Microbiome Therapeutics Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Microbiome Therapeutics Market Size Share by Type (2019-2024)
Table 9. Global Microbiome Therapeutics Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Microbiome Therapeutics Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Microbiome Therapeutics Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Microbiome Therapeutics Market Size Share by Application (2019-2024)
Table 24. Global Microbiome Therapeutics Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Microbiome Therapeutics Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Microbiome Therapeutics Industry Trends
Table 37. Microbiome Therapeutics Industry Drivers
Table 38. Microbiome Therapeutics Industry Opportunities and Challenges
Table 39. Microbiome Therapeutics Industry Restraints
Table 40. Global Microbiome Therapeutics Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Microbiome Therapeutics Revenue Market Share by Company (2019-2024)
Table 42. Global Microbiome Therapeutics Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Microbiome Therapeutics Key Company Headquarters & Area Served
Table 44. Global Microbiome Therapeutics Company, Product Type & Application
Table 45. Global Microbiome Therapeutics Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Microbiome Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Seres Therapeutics Business Overview
Table 49. Seres Therapeutics Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Seres Therapeutics Microbiome Therapeutics Product Portfolio
Table 51. Seres Therapeutics Recent Development
Table 52. Assembly Biosciences Company Information
Table 53. Assembly Biosciences Business Overview
Table 54. Assembly Biosciences Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Assembly Biosciences Microbiome Therapeutics Product Portfolio
Table 56. Assembly Biosciences Recent Development
Table 57. Synthetic Biologics Company Information
Table 58. Synthetic Biologics Business Overview
Table 59. Synthetic Biologics Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Synthetic Biologics Microbiome Therapeutics Product Portfolio
Table 61. Synthetic Biologics Recent Development
Table 62. Interxon Company Information
Table 63. Interxon Business Overview
Table 64. Interxon Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Interxon Microbiome Therapeutics Product Portfolio
Table 66. Interxon Recent Development
Table 67. PureTech Company Information
Table 68. PureTech Business Overview
Table 69. PureTech Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. PureTech Microbiome Therapeutics Product Portfolio
Table 71. PureTech Recent Development
Table 72. Synlogic Company Information
Table 73. Synlogic Business Overview
Table 74. Synlogic Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Synlogic Microbiome Therapeutics Product Portfolio
Table 76. Synlogic Recent Development
Table 77. Enterome BioScience Company Information
Table 78. Enterome BioScience Business Overview
Table 79. Enterome BioScience Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Enterome BioScience Microbiome Therapeutics Product Portfolio
Table 81. Enterome BioScience Recent Development
Table 82. 4D Pharma Company Information
Table 83. 4D Pharma Business Overview
Table 84. 4D Pharma Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. 4D Pharma Microbiome Therapeutics Product Portfolio
Table 86. 4D Pharma Recent Development
Table 87. Second Genome Company Information
Table 88. Second Genome Business Overview
Table 89. Second Genome Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Second Genome Microbiome Therapeutics Product Portfolio
Table 91. Second Genome Recent Development
Table 92. AOBiome Company Information
Table 93. AOBiome Business Overview
Table 94. AOBiome Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. AOBiome Microbiome Therapeutics Product Portfolio
Table 96. AOBiome Recent Development
Table 97. C3 Jian Company Information
Table 98. C3 Jian Business Overview
Table 99. C3 Jian Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. C3 Jian Microbiome Therapeutics Product Portfolio
Table 101. C3 Jian Recent Development
Table 102. Rebiotix Company Information
Table 103. Rebiotix Business Overview
Table 104. Rebiotix Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Rebiotix Microbiome Therapeutics Product Portfolio
Table 106. Rebiotix Recent Development
Table 107. MicroBiome Therapeutics LLC Company Information
Table 108. MicroBiome Therapeutics LLC Business Overview
Table 109. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Portfolio
Table 111. MicroBiome Therapeutics LLC Recent Development
Table 112. Metabiomics Company Information
Table 113. Metabiomics Business Overview
Table 114. Metabiomics Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. Metabiomics Microbiome Therapeutics Product Portfolio
Table 116. Metabiomics Recent Development
Table 117. Ritter Pharmaceuticals Company Information
Table 118. Ritter Pharmaceuticals Business Overview
Table 119. Ritter Pharmaceuticals Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
Table 121. Ritter Pharmaceuticals Recent Development
Table 122. Symberix Company Information
Table 123. Symberix Business Overview
Table 124. Symberix Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 125. Symberix Microbiome Therapeutics Product Portfolio
Table 126. Symberix Recent Development
Table 127. OpenBiome Company Information
Table 128. OpenBiome Business Overview
Table 129. OpenBiome Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 130. OpenBiome Microbiome Therapeutics Product Portfolio
Table 131. OpenBiome Recent Development
Table 132. Azitra Company Information
Table 133. Azitra Business Overview
Table 134. Azitra Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 135. Azitra Microbiome Therapeutics Product Portfolio
Table 136. Azitra Recent Development
Table 137. Symbiotix Biotherapies Company Information
Table 138. Symbiotix Biotherapies Business Overview
Table 139. Symbiotix Biotherapies Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 140. Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
Table 141. Symbiotix Biotherapies Recent Development
Table 142. Osel Company Information
Table 143. Osel Business Overview
Table 144. Osel Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 145. Osel Microbiome Therapeutics Product Portfolio
Table 146. Osel Recent Development
Table 147. Metabogen Company Information
Table 148. Metabogen Business Overview
Table 149. Metabogen Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 150. Metabogen Microbiome Therapeutics Product Portfolio
Table 151. Metabogen Recent Development
Table 152. North America Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. North America Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 154. North America Microbiome Therapeutics Market Share by Country (2019-2024)
Table 155. North America Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. North America Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 157. Europe Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 158. Europe Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 159. Europe Microbiome Therapeutics Market Share by Country (2019-2024)
Table 160. Europe Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 161. Europe Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 162. Asia-Pacific Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 163. Asia-Pacific Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 164. Asia-Pacific Microbiome Therapeutics Market Share by Country (2019-2024)
Table 165. Asia-Pacific Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 166. Asia-Pacific Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 167. Latin America Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 168. Latin America Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 169. Latin America Microbiome Therapeutics Market Share by Country (2019-2024)
Table 170. Latin America Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 171. Latin America Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 172. Middle East & Africa Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 173. Middle East & Africa Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 174. Middle East & Africa Microbiome Therapeutics Market Share by Country (2019-2024)
Table 175. Middle East & Africa Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 176. Middle East & Africa Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 177. Research Programs/Design for This Report
Table 178. Authors List of This Report
Table 179. Secondary Sources
Table 180. Primary Sources
Table 1. Global Microbiome Therapeutics Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Microbiome Therapeutics Market Share by Region (2019-2024)
Table 4. Global Microbiome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Microbiome Therapeutics Market Share by Region (2025-2030)
Table 6. Global Microbiome Therapeutics Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Microbiome Therapeutics Market Size Share by Type (2019-2024)
Table 9. Global Microbiome Therapeutics Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Microbiome Therapeutics Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Microbiome Therapeutics Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Microbiome Therapeutics Market Size Share by Application (2019-2024)
Table 24. Global Microbiome Therapeutics Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Microbiome Therapeutics Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Microbiome Therapeutics Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Microbiome Therapeutics Industry Trends
Table 37. Microbiome Therapeutics Industry Drivers
Table 38. Microbiome Therapeutics Industry Opportunities and Challenges
Table 39. Microbiome Therapeutics Industry Restraints
Table 40. Global Microbiome Therapeutics Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Microbiome Therapeutics Revenue Market Share by Company (2019-2024)
Table 42. Global Microbiome Therapeutics Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Microbiome Therapeutics Key Company Headquarters & Area Served
Table 44. Global Microbiome Therapeutics Company, Product Type & Application
Table 45. Global Microbiome Therapeutics Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Microbiome Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Seres Therapeutics Business Overview
Table 49. Seres Therapeutics Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Seres Therapeutics Microbiome Therapeutics Product Portfolio
Table 51. Seres Therapeutics Recent Development
Table 52. Assembly Biosciences Company Information
Table 53. Assembly Biosciences Business Overview
Table 54. Assembly Biosciences Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Assembly Biosciences Microbiome Therapeutics Product Portfolio
Table 56. Assembly Biosciences Recent Development
Table 57. Synthetic Biologics Company Information
Table 58. Synthetic Biologics Business Overview
Table 59. Synthetic Biologics Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Synthetic Biologics Microbiome Therapeutics Product Portfolio
Table 61. Synthetic Biologics Recent Development
Table 62. Interxon Company Information
Table 63. Interxon Business Overview
Table 64. Interxon Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Interxon Microbiome Therapeutics Product Portfolio
Table 66. Interxon Recent Development
Table 67. PureTech Company Information
Table 68. PureTech Business Overview
Table 69. PureTech Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. PureTech Microbiome Therapeutics Product Portfolio
Table 71. PureTech Recent Development
Table 72. Synlogic Company Information
Table 73. Synlogic Business Overview
Table 74. Synlogic Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Synlogic Microbiome Therapeutics Product Portfolio
Table 76. Synlogic Recent Development
Table 77. Enterome BioScience Company Information
Table 78. Enterome BioScience Business Overview
Table 79. Enterome BioScience Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Enterome BioScience Microbiome Therapeutics Product Portfolio
Table 81. Enterome BioScience Recent Development
Table 82. 4D Pharma Company Information
Table 83. 4D Pharma Business Overview
Table 84. 4D Pharma Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. 4D Pharma Microbiome Therapeutics Product Portfolio
Table 86. 4D Pharma Recent Development
Table 87. Second Genome Company Information
Table 88. Second Genome Business Overview
Table 89. Second Genome Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Second Genome Microbiome Therapeutics Product Portfolio
Table 91. Second Genome Recent Development
Table 92. AOBiome Company Information
Table 93. AOBiome Business Overview
Table 94. AOBiome Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. AOBiome Microbiome Therapeutics Product Portfolio
Table 96. AOBiome Recent Development
Table 97. C3 Jian Company Information
Table 98. C3 Jian Business Overview
Table 99. C3 Jian Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. C3 Jian Microbiome Therapeutics Product Portfolio
Table 101. C3 Jian Recent Development
Table 102. Rebiotix Company Information
Table 103. Rebiotix Business Overview
Table 104. Rebiotix Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Rebiotix Microbiome Therapeutics Product Portfolio
Table 106. Rebiotix Recent Development
Table 107. MicroBiome Therapeutics LLC Company Information
Table 108. MicroBiome Therapeutics LLC Business Overview
Table 109. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Portfolio
Table 111. MicroBiome Therapeutics LLC Recent Development
Table 112. Metabiomics Company Information
Table 113. Metabiomics Business Overview
Table 114. Metabiomics Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. Metabiomics Microbiome Therapeutics Product Portfolio
Table 116. Metabiomics Recent Development
Table 117. Ritter Pharmaceuticals Company Information
Table 118. Ritter Pharmaceuticals Business Overview
Table 119. Ritter Pharmaceuticals Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
Table 121. Ritter Pharmaceuticals Recent Development
Table 122. Symberix Company Information
Table 123. Symberix Business Overview
Table 124. Symberix Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 125. Symberix Microbiome Therapeutics Product Portfolio
Table 126. Symberix Recent Development
Table 127. OpenBiome Company Information
Table 128. OpenBiome Business Overview
Table 129. OpenBiome Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 130. OpenBiome Microbiome Therapeutics Product Portfolio
Table 131. OpenBiome Recent Development
Table 132. Azitra Company Information
Table 133. Azitra Business Overview
Table 134. Azitra Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 135. Azitra Microbiome Therapeutics Product Portfolio
Table 136. Azitra Recent Development
Table 137. Symbiotix Biotherapies Company Information
Table 138. Symbiotix Biotherapies Business Overview
Table 139. Symbiotix Biotherapies Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 140. Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
Table 141. Symbiotix Biotherapies Recent Development
Table 142. Osel Company Information
Table 143. Osel Business Overview
Table 144. Osel Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 145. Osel Microbiome Therapeutics Product Portfolio
Table 146. Osel Recent Development
Table 147. Metabogen Company Information
Table 148. Metabogen Business Overview
Table 149. Metabogen Microbiome Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 150. Metabogen Microbiome Therapeutics Product Portfolio
Table 151. Metabogen Recent Development
Table 152. North America Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. North America Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 154. North America Microbiome Therapeutics Market Share by Country (2019-2024)
Table 155. North America Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. North America Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 157. Europe Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 158. Europe Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 159. Europe Microbiome Therapeutics Market Share by Country (2019-2024)
Table 160. Europe Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 161. Europe Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 162. Asia-Pacific Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 163. Asia-Pacific Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 164. Asia-Pacific Microbiome Therapeutics Market Share by Country (2019-2024)
Table 165. Asia-Pacific Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 166. Asia-Pacific Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 167. Latin America Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 168. Latin America Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 169. Latin America Microbiome Therapeutics Market Share by Country (2019-2024)
Table 170. Latin America Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 171. Latin America Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 172. Middle East & Africa Microbiome Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 173. Middle East & Africa Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 174. Middle East & Africa Microbiome Therapeutics Market Share by Country (2019-2024)
Table 175. Middle East & Africa Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 176. Middle East & Africa Microbiome Therapeutics Market Share Forecast by Country (2025-2030)
Table 177. Research Programs/Design for This Report
Table 178. Authors List of This Report
Table 179. Secondary Sources
Table 180. Primary Sources
LIST OF FIGURES
Figure 1. Microbiome Therapeutics Product Picture
Figure 2. Global Microbiome Therapeutics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 4. Global Microbiome Therapeutics Market Share by Region: 2023 VS 2030
Figure 5. Global Microbiome Therapeutics Market Share by Region (2019-2030)
Figure 6. North America Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Upper GIT
Figure 12. Global Upper GIT Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Lower GIT
Figure 14. Global Lower GIT Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Global Microbiome Therapeutics Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 16. Global Microbiome Therapeutics Market Share by Type 2023 VS 2030
Figure 17. North America Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 18. Europe Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 19. Asia-Pacific Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 20. Latin America Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 21. Middle East and Africa Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 22. Product Picture of C. difficile Infection (CDI)
Figure 23. Global C. difficile Infection (CDI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Product Picture of Inflammatory Bowel Disease (IBD)
Figure 25. Global Inflammatory Bowel Disease (IBD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Product Picture of Orphan Drug
Figure 27. Global Orphan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Product Picture of Immuno-oncology
Figure 29. Global Immuno-oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Others
Figure 31. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Global Microbiome Therapeutics Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 33. Global Microbiome Therapeutics Market Share by Application 2023 VS 2030
Figure 34. North America Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 35. Europe Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 36. Asia-Pacific Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 37. Latin America Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 38. Middle East and Africa Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 39. Global Top 5 and 10 Microbiome Therapeutics Players Market Share by Revenue in 2023
Figure 40. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. North America Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 44. Europe Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 45. Europe Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 46. Europe Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 47. Asia-Pacific Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Asia-Pacific Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 50. Latin America Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Latin America Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Latin America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Middle East & Africa Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East & Africa Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 56. Years Considered
Figure 57. Research Process
Figure 58. Key Executives Interviewed
Figure 1. Microbiome Therapeutics Product Picture
Figure 2. Global Microbiome Therapeutics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Microbiome Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 4. Global Microbiome Therapeutics Market Share by Region: 2023 VS 2030
Figure 5. Global Microbiome Therapeutics Market Share by Region (2019-2030)
Figure 6. North America Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Microbiome Therapeutics Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Upper GIT
Figure 12. Global Upper GIT Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Lower GIT
Figure 14. Global Lower GIT Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Global Microbiome Therapeutics Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 16. Global Microbiome Therapeutics Market Share by Type 2023 VS 2030
Figure 17. North America Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 18. Europe Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 19. Asia-Pacific Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 20. Latin America Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 21. Middle East and Africa Microbiome Therapeutics Market Size Share by Type (2019-2030)
Figure 22. Product Picture of C. difficile Infection (CDI)
Figure 23. Global C. difficile Infection (CDI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Product Picture of Inflammatory Bowel Disease (IBD)
Figure 25. Global Inflammatory Bowel Disease (IBD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Product Picture of Orphan Drug
Figure 27. Global Orphan Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Product Picture of Immuno-oncology
Figure 29. Global Immuno-oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Others
Figure 31. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Global Microbiome Therapeutics Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 33. Global Microbiome Therapeutics Market Share by Application 2023 VS 2030
Figure 34. North America Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 35. Europe Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 36. Asia-Pacific Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 37. Latin America Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 38. Middle East and Africa Microbiome Therapeutics Market Size Share by Application (2019-2030)
Figure 39. Global Top 5 and 10 Microbiome Therapeutics Players Market Share by Revenue in 2023
Figure 40. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. North America Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 44. Europe Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 45. Europe Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 46. Europe Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 47. Asia-Pacific Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Asia-Pacific Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 50. Latin America Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Latin America Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Latin America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Microbiome Therapeutics Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Middle East & Africa Microbiome Therapeutics Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East & Africa Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 56. Years Considered
Figure 57. Research Process
Figure 58. Key Executives Interviewed
